Treatment Decision-making in Patients With Recurrent High-grade Glioma
NCT ID: NCT04013828
Last Updated: 2022-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
29 participants
OBSERVATIONAL
2019-05-06
2022-04-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long Term Survivors of High-grade Glioma and Their Caregivers
NCT02965144
Nurse-led Family and Network Consultations
NCT03458312
Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers
NCT01638130
Nimotuzumab in Children With HGG
NCT00561873
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
NCT00967200
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this situation the patients and their close relatives need to make a difficult balancing between benefits and trade offs.
Little is known about how the patients and their close relatives experience the recurrence and the decision-making process.
The objective of this study is therefore to explore the perspectives, experiences and needs in patients and their close relatives in relation to the decision-making process at time of recurrence.
Data will be generated through semi-structured interviews. Interviews will be analysed and interpreted using a Ricoeur inspired method of qualitative analysis.
The study is part of a larger PhD-study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients
Patients with recurrent high-grade glioma
No interventions assigned to this group
Relatives
Close relatives of patients with recurrent high-grade glioma
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to speak and understand danish
* Able to participate in an interview
* Able to give informed concent for participation
Exclusion Criteria
* Relatives are excluded if the patient do not give concent for the participation of relatives
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Region of Southern Denmark
OTHER
Danish Cancer Society
OTHER
Novo Nordisk A/S
INDUSTRY
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helle Sørensen von Essen
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frantz Rom Poulsen, Professor
Role: STUDY_DIRECTOR
Department of Neurosurgery Odense University Hospital DK-5000 Odense C DENMARK
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital; Rigshospitalet
Copenhagen, , Denmark
Odense University Hospital
Odense, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OP870
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.